The counter-regulatory effects of ESE-1 during angiotensin II-mediated vascular inflammation and remodeling

American Journal of Hypertension

Volumn 23, Issue 12, 2010, Pages 1312-1317

  Zhan, Yumei ^a   Yuan, Lei ^a   Kondo, Maiko ^a   Oettgen, Peter ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

blood pressure; ETS factors; gene transcription; hypertension

Indexed keywords

ANGIOTENSIN II; CYCLINE; INDUCIBLE NITRIC OXIDE SYNTHASE; TRANSCRIPTION FACTOR ETS 1; DNA BINDING PROTEIN; ELF3 PROTEIN, MOUSE; NOS2 PROTEIN, MOUSE; TRANSCRIPTION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; CARDIOVASCULAR RESPONSE; CELL INFILTRATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; KNOCKOUT MOUSE; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; STAINING; SYSTOLIC BLOOD PRESSURE; T LYMPHOCYTE; VASCULAR FIBROSIS; VASCULITIS; WILD TYPE; ANIMAL; AORTA; ARTICLE; BIOSYNTHESIS; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; HYPERTENSION; METABOLISM; MOUSE MUTANT; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR ENDOTHELIUM;

ANGIOTENSIN II; ANIMALS; AORTA; DNA-BINDING PROTEINS; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION; MALE; MICE; MICE, KNOCKOUT; NITRIC OXIDE SYNTHASE TYPE II; TRANSCRIPTION FACTORS; VASCULITIS;

EID: 79952278651     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1038/ajh.2010.164     Document Type: Review

References (35)

1. Nunn MF, Seeburg PH, Moscovici C, Duesberg PH. Tripartite structure of the avian erythroblastosis virus E26 transforming gene. Nature 1983; 306:391-395. (Pubitemid 14242755)
2. Lepage A, Uzan G, Touche N, Morales M, Cazenave JP, Lanza F, de La Salle C. Functional characterization of the human platelet glycoprotein V gene promoter: a specific marker of late megakaryocytic differentiation. Blood 1999; 94:3366-3380. (Pubitemid 29536131)
3. Wasylyk B, Hahn SL, Giovane A. The Ets family of transcription factors. Eur J Biochem 1993; 211:7-18. (Pubitemid 23039491)
4. Seth A, Watson DK. ETS transcription factors and their emerging roles in human cancer. Eur J Cancer 2005; 41:2462-2478. (Pubitemid 41540623)
5. Oikawa T, Yamada T. Molecular biology of the Ets family of transcription factors. Gene 2003; 303:11-34. (Pubitemid 36151767)
6. Oettgen P, Alani RM, Barcinski MA, Brown L, Akbarali Y, Boltax J, Kunsch C, Munger K, Libermann TA. Isolation and characterization of a novel epitheliumspecific transcription factor, ESE-1, a member of the ets family. Mol Cell Biol 1997; 17:4419-4433. (Pubitemid 27318119)
7. Rudders S, Gaspar J, Madore R, Voland C, Grall F, Patel A, Pellacani A, Perrella MA, Libermann TA, Oettgen P. ESE-1 is a novel transcriptional mediator of inflammation that interacts with NF-kappa B to regulate the inducible nitric?oxide synthase gene. J Biol Chem 2001; 276:3302-3309.
8. Grall FT, Prall WC, Wei W, Gu X, Cho JY, Choy BK, Zerbini LF, Inan MS, Goldring SR, Gravallese EM, Goldring MB, Oettgen P, Libermann TA. The Ets transcription factor ESE-1 mediates induction of the COX-2 gene by LPS in monocytes. FEBS J 2005; 272:1676-1687. (Pubitemid 40516218)
9. Brown C, Gaspar J, Pettit A, Lee R, Gu X, Wang H, Manning C, Voland C, Goldring SR, Goldring MB, Libermann TA, Gravallese EM, Oettgen P. ESE-1 is a novel transcriptional mediator of angiopoietin-1 expression in the setting of inflammation. J Biol Chem 2004; 279:12794-12803. (Pubitemid 38445852)
10. Wang H, Fang R, Cho JY, Libermann TA, Oettgen P. Positive and negative modulation of the transcriptional activity of the ETS factor ESE-1 through interaction with p300, CREB-binding protein, and Ku 70/86. J Biol Chem 2004; 279:25241-25250. (Pubitemid 38756776)
11. Zhan Y, Brown C, Maynard E, Anshelevich A, Ni W, Ho IC, Oettgen P. Ets-1 is a critical regulator of Ang II-mediated vascular inflammation and remodeling. J Clin Invest 2005; 115:2508-2516. (Pubitemid 41266213)
12. Oettgen P. Regulation of vascular inflammation and remodeling by ETS factors. Circ Res 2006; 99:1159-1166. (Pubitemid 44808652)
13. Takemoto M, Egashira K, Usui M, Numaguchi K, Tomita H, Tsutsui H, Shimokawa H, Sueishi K, Takeshita A. Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockade of nitric oxide synthesis in rats. J Clin Invest 1997; 99:278-287. (Pubitemid 27053468)
14. Wu L, Iwai M, Nakagami H, Chen R, Suzuki J, Akishita M, de Gasparo M, Horiuchi M. Effect of angiotensin II type 1 receptor blockade on cardiac remodeling in angiotensin II type 2 receptor null mice. Arterioscler Thromb Vasc Biol 2002; 22: 49-54. (Pubitemid 34076231)
15. Ishibashi M, Egashira K, Zhao Q, Hiasa K, Ohtani K, Ihara Y, Charo IF, Kura S, Tsuzuki T, Takeshita A, Sunagawa K. Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic mice. Arterioscler Thromb Vasc Biol 2004; 24:e174-e178.
16. Phillips MI, Kagiyama S. Angiotensin II as a pro-inflammatory mediator. Curr Opin Investig Drugs 2002; 3:569-577.
17. Piqueras L, Kubes P, Alvarez A, O'Connor E, Issekutz AC, Esplugues JV, Sanz MJ. Angiotensin II induces leukocyte-endothelial cell interactions in vivo via AT(1) and AT(2) receptor-mediated P-selectin upregulation. Circulation 2000; 102:2118-2123.
18. Hultgårdh-Nilsson A, Cercek B, Wang JW, Naito S, Lövdahl C, Sharifi B, Forrester JS, Fagin JA. Regulated expression of the ets-1 transcription factor in vascular smooth muscle cells in vivo and in vitro. Circ Res 1996; 78:589-595. (Pubitemid 26106874)
19. Goetze S, Kintscher U, Kaneshiro K, Meehan WP, Collins A, Fleck E, Hsueh WA, Law RE. TNFalpha induces expression of transcription factors c-fos, Egr-1, and Ets-1 in vascular lesions through extracellular signal-regulated kinases. Atherosclerosis 2001; 159:93-101. (Pubitemid 33016626)
20. Naito S, Shimizu S, Maeda S, Wang J, Paul R, Fagin JA. Ets-1 is an early response gene activated by ET-1 and PDGF-BB in vascular smooth muscle cells. Am J Physiol 1998; 274:C472-C480.
21. Redlich K, Kiener HP, Schett G, Tohidast-Akrad M, Selzer E, Radda I, Stummvoll GH, Steiner CW, Gröger M, Bitzan P, Zenz P, Smolen JS, Steiner G. Overexpression of transcription factor Ets-1 in rheumatoid arthritis synovial membrane: regulation of expression and activation by interleukin-1 and tumor necrosis factor alpha. Arthritis Rheum 2001; 44:266-274. (Pubitemid 32207019)
22. Liu AY, Corey E, Vessella RL, Lange PH, True LD, Huang GM, Nelson PS, Hood L. Identification of differentially expressed prostate genes: increased expression of transcription factor ETS-2 in prostate cancer. Prostate 1997; 30:145-153. (Pubitemid 27149272)
23. Santiago FS, Khachigian LM. Ets-1 stimulates platelet-derived growth factor A-chain gene transcription and vascular smooth muscle cell growth via cooperative interactions with Sp1. Circ Res 2004; 95:479-487. (Pubitemid 39180928)
24. Dzau VJ. Theodore Cooper Lecture: tissue angiotensin and pathobiology of vascular disease: a unifying hypothesis. Hypertension 2001; 37:1047-1052. (Pubitemid 32304002)
25. Griendling KK, Sorescu D, Ushio-Fukai M. NAD(P)H oxidase: role in cardiovascular biology and disease. Circ Res 2000; 86:494-501. (Pubitemid 30165039)
26. Bonello MR, Bobryshev YV, Khachigian LM. Peroxide-inducible Ets-1 mediates platelet-derived growth factor receptor-alpha gene transcription in vascular smooth muscle cells. Am J Pathol 2005; 167:1149-1159. (Pubitemid 41416265)
27. Nakayama I, Kawahara Y, Tsuda T, Okuda M, Yokoyama M. Angiotensin II inhibits cytokine-stimulated inducible nitric oxide synthase expression in vascular smooth muscle cells. J Biol Chem 1994; 269:11628-11633. (Pubitemid 24200388)
28. Guzik TJ, Hoch NE, Brown KA, McCann LA, Rahman A, Dikalov S, Goronzy J, Weyand C, Harrison DG. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 2007; 204:2449-2460. (Pubitemid 47529329)
29. Qi Z, Hao CM, Langenbach RI, Breyer RM, Redha R, Morrow JD, Breyer MD. Opposite effects of cyclooxygenase-1 and-2 activity on the pressor response to angiotensin II. J Clin Invest 2002; 110:61-69. (Pubitemid 34743466)
30. Hao CM, Breyer MD. Physiologic and pathophysiologic roles of lipid mediators in the kidney. Kidney Int 2007; 71:1105-1115. (Pubitemid 46809137)
31. Peng H, Tan L, Osaki M, Zhan Y, Ijiri K, Tsuchimochi K, Otero M, Wang H, Choy BK, Grall FT, Gu X, Libermann TA, Oettgen P, Goldring MB. ESE-1 is a potent repressor of type II collagen gene (COL2A1) transcription in human chondrocytes. J Cell Physiol 2008; 215:562-573. (Pubitemid 351468968)
32. Chung SW, Chen YH, Yet SF, Layne MD, Perrella MA. Endotoxin-induced downregulation of Elk-3 facilitates heme oxygenase-1 induction in macrophages. J Immunol 2006; 176:2414-2420. (Pubitemid 43201691)
33. Chen YH, Yet SF, Perrella MA. Role of heme oxygenase-1 in the regulation of blood pressure and cardiac function. Exp Biol Med (Maywood) 2003; 228:447-453. (Pubitemid 37203658)
34. Chen YH, Layne MD, Chung SW, Ejima K, Baron RM, Yet SF, Perrella MA. Elk-3 is a transcriptional repressor of nitric-oxide synthase 2. J Biol Chem 2003; 278: 39572-39577. (Pubitemid 37248516)
35. Yuan L, Nikolova-Krstevski V, Zhan Y, Kondo M, Bhasin M, Varghese L, Yano K, Carman CV, Aird WC, Oettgen P. Antiinflammatory effects of the ETS factor ERG in endothelial cells are mediated through transcriptional repression of the interleukin-8 gene. Circ Res 2009; 104:1049-1057.